Sources, impacts and trends of pharmaceuticals in the marine and coastal environment.
Leveraging existing data for prioritization of the ecological risks of human and veterinary pharmaceuticals to aquatic organisms.
Comparative metabolism as a key driver of wildlife species sensitivity to human and veterinary pharmaceuticals.
Assessing variation in the potential susceptibility of fish to pharmaceuticals, considering evolutionary differences in their physiology and ecology.
A network biology workflow to study transcriptomics data of the diabetic liver.
Systematic analysis of new drug indications by drug-gene-disease coherent subnetworks.
Identification of novel tyrosine kinase inhibitors for drug resistant T315I mutant BCR-ABL: a virtual screening and molecular dynamics simulations study.
A Systems Biology Approach to Understanding the Mechanisms of Action of an Alternative Anticancer Compound in Comparison to Cisplatin.
From microbial gene essentiality to novel antimicrobial drug targets.
A novel systems pharmacology model for herbal medicine injection: a case using Reduning injection.